Adverse outcome pathway

From WikiMD's Wellness Encyclopedia

Schematic representation of AOP with hypothetical events.jpg

Adverse Outcome Pathway (AOP) is a conceptual framework that portrays the progression of a toxicological effect from a molecular-level interaction through to an adverse health outcome at the individual or population level. The AOP framework is used to guide risk assessment in toxicology and environmental health, facilitating a better understanding of how chemical exposures lead to harmful outcomes. This approach is integral to the development of more accurate and predictive toxicology models, moving away from traditional animal testing methods towards more ethical and efficient in vitro and in silico methods.

Overview[edit | edit source]

An AOP is structured around a linear sequence of events starting with a Molecular Initiating Event (MIE)—the initial interaction of a chemical with a biological target—followed by a series of intermediate biological events leading to an Adverse Outcome at the organism or population level. This sequence is known as the AOP's pathway. The concept emphasizes the causal relationships between these events, providing a detailed mechanism of action and facilitating the identification of potential intervention points to prevent or mitigate adverse outcomes.

Key Components[edit | edit source]

The key components of an AOP include:

Development and Application[edit | edit source]

The development of an AOP requires a comprehensive understanding of the toxicological mechanism of action, supported by both experimental data and computational models. AOPs are developed and curated within the AOP Wiki, a collaborative platform that allows scientists to contribute and access AOP-related information. The use of AOPs in regulatory toxicology aims to support decision-making by providing mechanistic insights into the effects of chemical exposures, thereby improving the prediction and assessment of chemical risks to human health and the environment.

Challenges and Future Directions[edit | edit source]

While the AOP framework offers significant advantages, there are challenges in its implementation, including the need for extensive experimental data to validate the pathways and the complexity of modeling non-linear and cross-talk pathways. Future directions in AOP research focus on the integration of AOPs with other data-rich approaches, such as systems biology and big data analytics, to enhance the predictive power of toxicological assessments and support the development of safer chemicals and materials.

See Also[edit | edit source]

Adverse outcome pathway Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD